LG-0317
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LG-0317, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 in Healthy Participants [Phase 1]